Close

Coherus BioSciences (CHRS) Reports Q3 Loss Per Share of $1.86

November 9, 2015 4:43 PM EST

Coherus BioSciences (NASDAQ: CHRS) reported Q3 EPS of ($1.86), versus ($1.79) reported last year. Revenue for the quarter came in at $7.2 million, versus $16.1 million reported last year.

For earnings history and earnings-related data on Coherus BioSciences (CHRS) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings